You are here: All Products  > KeChow Approved to Launch Tunlametinib for Melanoma Patients in China

KeChow Approved to Launch Tunlametinib for Melanoma Patients in China

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products